UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000002783 |
|---|---|
| Receipt number | R000003384 |
| Scientific Title | A phase II study of gefitinib as first-line treatment for elderly patients with advanced lung adenocarcinoma who have active EGFR mutations |
| Date of disclosure of the study information | 2009/11/19 |
| Last modified on | 2012/05/28 13:14:34 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2009/11/19 11:20:34 | ||
| 2 | Update | 2011/02/07 06:38:40 | Name of person sending information Organization Division name Address |
|
| 3 | Update | 2011/02/07 06:39:23 | Publication of results |
|
| 4 | Update | 2011/06/12 09:28:02 | Publication of results |
|
| 5 | Update | 2012/05/28 13:14:34 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
